ATI RN
ATI RN Pharmacology 2023 V Questions
Extract:
Question 1 of 5
A nurse is caring for a client who has a new prescription for mirtazapine. Which of the following medications should the nurse identify as a contraindication to the client's new prescription?
Correct Answer: C
Rationale: The correct answer is C: Linezolid. Linezolid is a monoamine oxidase inhibitor (MAOI), and concurrent use with mirtazapine, which is a serotonin modulator, can lead to serotonin syndrome due to excessive serotonin accumulation. Hydroxyzine (
A) is an antihistamine, Clozapine (
B) is an antipsychotic, and Nortriptyline (
D) is a tricyclic antidepressant, none of which are contraindicated with mirtazapine.
Question 2 of 5
A nurse is caring for a client who is receiving parenteral nutrition and identifies that the client has hypoglycemia. Which of the following actions should the nurse take?
Correct Answer: C
Rationale: The correct action is to administer IV dextrose (
Choice
C) to treat hypoglycemia in a client receiving parenteral nutrition. This is because hypoglycemia can occur when the body's glucose levels drop too low, which can be dangerous. Administering IV dextrose will help increase the client's blood sugar levels quickly and effectively. Discontinuing the infusion (
Choice
A) may worsen the hypoglycemia by removing a potential source of glucose. Obtaining arterial blood gases (
Choice
B) is not necessary for treating hypoglycemia. Warming the formula to room temperature (
Choice
D) does not address the immediate need to raise the client's blood sugar levels.
Question 3 of 5
A nurse is preparing to administer total parenteral nutrition to a client. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: The correct answer is B: Keep the solution refrigerated until 1 hr before infusion.
Total parenteral nutrition solutions should be stored in the refrigerator to maintain stability and prevent bacterial growth. By keeping the solution refrigerated until 1 hour before infusion, the nurse ensures that the solution remains safe for administration.
Incorrect choices:
A: Obtaining the client's weight three times a week is unrelated to the administration of total parenteral nutrition.
C: Changing the solution every 36 hours is not necessary and may lead to unnecessary waste.
D: Checking the client's WBC count daily is not directly related to the administration of total parenteral nutrition.
Question 4 of 5
A nurse is assessing a client who is taking warfarin. Which of the following findings should the nurse identify as the priority to report to the provider?
Correct Answer: A
Rationale: The correct answer is A: Melena. Melena is a serious side effect of warfarin, indicating gastrointestinal bleeding. This is a priority because it can lead to life-threatening complications. Abdominal cramping (
B) could also be concerning but is not as urgent as melena. Fever (
C) is not directly related to warfarin use. Hair loss (
D) is not typically associated with warfarin and is a lower priority.
Question 5 of 5
A nurse is developing a teaching plan for an older adult client who has a new prescription for insulin glargine. Which of the following expected outcomes should the nurse include in the plan?
Correct Answer: A
Rationale: The correct answer is A: The client will wear his reading glasses when drawing up a dose of insulin glargine. This is crucial to ensure accurate dosing and prevent medication errors, especially for older adults who may have visual impairments. Wearing reading glasses can help the client see the markings on the syringe clearly, ensuring they draw up the correct dose.
Choices B, C, and D are incorrect:
B: Taking an additional dose of insulin glargine prior to exercise is not appropriate without proper guidance from a healthcare provider as it can lead to hypoglycemia.
C: Administering insulin glargine before each meal is not correct as insulin glargine is a long-acting insulin and is usually administered once daily at the same time each day.
D: Using the deltoid muscle as an injection site is not recommended for insulin glargine as it is typically injected subcutaneously into the abdomen, thigh, or upper arm for consistent absorption.